ORKT
OrangekloudCAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
This is a low-conviction monitoring memo. The evidence packet had no recent news, no stored earnings materials, no social context, and no built-in primary notes, so the thesis relies mainly on a small set of company and SEC sources checked directly. Those sources are more about listing status, a potential reverse merger, partnerships, and balance-sheet capacity than about broad operating proof, which keeps tone cautious. As of June 24, 2026, the anchor price was $1.20, only modestly above the $1 minimum-bid threshold that already caused a Nasdaq delisting process earlier in 2026.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Orangekloud's 2025 Form 20-F said cash and cash equivalents fell to about S$3.0 million from S$8.2 million, working capital fell to about S$2.9 million from S$11.0 million, and the company may tap capital markets or bank credit toward Q4 2026 despite saying current resources should cover 2026 needs [#SEC-20F-2026-04-30].
The February 11, 2026 Form 6-K disclosed a non-binding LOI with Orbis, and the March 3, 2026 Form 6-K said negotiations were still active but needed more time; if completed, current Orangekloud holders would own a minority stake, making this a highly dilutive and binary corporate event rather than a clean operating catalyst [#SEC-6K-2026-02-11] [#SEC-6K-2026-03-03].
Company sources show eMOBIQ AI launched on July 25, 2025, the 2025 20-F reported no-code-platform revenue rose 154% year over year to about S$2.0 million, and a March 16, 2026 partnership with Intellsync targets Malaysian SME deployment; the open question is whether those launches and partnerships become durable booked revenue at meaningful scale [#PR-2025-07-25] [#SEC-20F-2026-04-30] [#PR-2026-03-16].
Recommendation
No formal recommendation provided.

